Filing Details

Accession Number:
0001209191-10-028405
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-18 13:00:00
Reporting Period:
2010-05-17
Filing Date:
2010-05-18
Accepted Time:
2010-05-18 06:05:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087432 Intermune Inc ITMN Pharmaceutical Preparations (2834) 943296648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1301008 Joan Robin Steele 3280 Bayshore Boulevard
Brisbane CA 94005
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-13 1,458 $10.84 47,866 No 4 S Direct
Common Stock Acquisiton 2010-05-17 958 $10.52 46,908 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reporting person sold the noted securities in connection with the vesting of 1,458 shares on 5/13/10 (which represents a portion of the previously reported equity incentive grant made on 5/13/2008) and 958 shares on 5/17/10 (which represents a portion of the previously reported equity incentive grant made on 5/15/2007). The sale of these shares were made pursuant to a written trading plan entered into in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, which was previously disclosed by InterMune in reports on Forms 8-K filed on March 13, 2009, June 18, 2008 and September 7, 2007.